<DOC>
	<DOCNO>NCT00679250</DOCNO>
	<brief_summary>Allergic rhinitis common condition characterize inflammation upper airway . Third generation antihistamine demonstrate effective treatment condition . Allergen challenge use assess effect drug allergic rhinitis , adenosine monophosphate may also use mean investigate effect yet effect yet compare allergen challenge . We intend compare effect levocetirizine single dose 5mg allergen AMP challenge compare placebo double blind cross-over study . The study include 20 patient allergic rhinitis . Each patient allergen AMP challenge placebo active treatment . The primary outcome variable change concentration AMP/Allergen require produce 20 % drop nasal flow manifest peak nasal inspiratory flow . A 1 double dose change concentration challenge medium cause 20 % drop nasal flow deem significant . We also measure time recovery challenge . AMP challenge safe alternative allergen challenge risk anaphylaxis .</brief_summary>
	<brief_title>To Evaluate Adenosine Monophosphate Allergen Challenge Allergic Rhinitis</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Adenosine</mesh_term>
	<mesh_term>Levocetirizine</mesh_term>
	<mesh_term>Cetirizine</mesh_term>
	<criteria>Male female 1675 Patients persistent rhinitis must skin prick positive house dust mite perennial symptom Patients seasonal rhinitis skin prick positive grass/tree pollen seasonal symptom Concomitant asthma permit rhinitis FEV1 &gt; 60 % No recent exacerbation asthma chest infection asthmatic Able perform technique necessary carry challenge test Must compliant study medication Must give informed consent Male female outwith age range Negative skin prick test Patients concomitant asthma FEV1 le 60 % predict Patients asthma recent chest infection exacerbation Pregnant female , risk become pregnant breast feeding . Females must adequate contraception whole study period</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2008</verification_date>
	<keyword>allergic rhinitis</keyword>
	<keyword>levocetirizine</keyword>
	<keyword>nasal provocation test</keyword>
	<keyword>nasal allergen challenge</keyword>
	<keyword>nasal adenosine monophosphate challenge</keyword>
</DOC>